Arbor Vita Announces OncoE6™ Cervical Test Interim Study Results

Arbor Vita has announced interim clinical study results for the Company's OncoE6™ Cervical Test for cervical cancer and precancerous lesions. Results validated the utility of Arbor Vita's OncoE6™ Cervical Test to detect the cancer-causing E6 protein, a biomarker for cervical cancer and precancerous lesions. The E6 oncoprotein is expressed at elevated levels in cervical swab samples only when HPV-infected cervical cells undergo precancerous and cancerous changes. The study findings were presented at the 27th International Papillomavirus Conference (IPV) in Berlin, Germany. Read more...